TD Cowen lifts Regeneron stock PT to $1,030 despite recent pullback By Investing.com

Published on 24 Apr 2024 on Investing.com

On Wednesday, TD (TSX:TD) Cowen showed confidence in Regeneron Pharmaceuticals Inc (NASDAQ:REGN),...

Read the rest of the article

Start tracking your investments with Statfolio

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2024 Earnings Call Transcript May 2, 2024 Regene...

Insider Monkey via Yahoo Finance 3 May 2024

On Thursday, Regeneron Pharmaceuticals Inc REGN reported first-quarter adjusted EPS of $9.55, dow...

Benzinga 2 May 2024

It is hard to get excited after looking at Regeneron Pharmaceuticals' (NASDAQ:REGN) recent perfor...

Simply Wall St. via Yahoo Finance 2 May 2024

Regeneron showcases robust product sales growth amidst competitive pharmaceutical landscape.Strat...

GuruFocus.com via Yahoo Finance 2 May 2024

Regeneron Pharmaceuticals, Inc. REGN delivered lower-than-expected first-quarter 2024 results due...

Zacks via Yahoo Finance 2 May 2024

(Reuters) -U.S. drugmaker Regeneron Pharmaceuticals Inc missed Wall Street estimates for quarterl...

Reuters via Yahoo Finance 1 May 2024

The first-quarter 2024 reporting cycle of the Medical sector is currently in full swing. The sect...

Zacks via Yahoo Finance 30 Apr 2024

Biotech giant Regeneron Pharmaceuticals, Inc. REGN is slated to report first-quarter results on M...

Zacks via Yahoo Finance 30 Apr 2024

In this article, we will take a look at the 11 oversold growth stocks to buy right now. To skip o...

Insider Monkey via Yahoo Finance 28 Apr 2024

Regeneron Pharmaceuticals and Mammoth Biosciences join forces to develop CRISPR-based gene editin...

Seeking Alpha 25 Apr 2024